Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Divi's Laboratories hits 2-1/2-year low on Q3 profit slump

** Shares of pharmaceutical company Divi's Laboratories Ltd
 DIVI.NS  fall as much as 9.4% to 2,961.2 rupees, its lowest
level since Aug. 7, 2020
    ** Stock posts biggest intraday pct decline since May 23,
2022 
    ** Co reports a 66% drop in Q3 consolidated net profit at
3.07 billion rupees ($37.33 million) 
    ** Analysts had expected, on average, profit of 5.33 bln
rupees - Refinitiv IBES
    ** Co says change in product mix led to material consumption
in the quarter being about 43% of sales revenue
    ** Ahead of DIVI's results brokerage Jefferies said earnings
were to be muted on lack of growth factors; adds that growth
strength in FY24 uncertain as well
    ** Six of the 22 analysts rate the stock "buy" or higher, 7
"hold", 9 "sell" or lower; median PT is 3,375 rupees - Refinitiv
data
    ** Over 1 mln shares traded as of 1:07 pm IST, thrice the
30-day moving average
    ** Stock fell 27% in 2022
($1 = 82.2300 Indian rupees)
 (Reporting by Varun Vyas in Bengaluru)
 ((varunvyas.hebbalalu@thomsonreuters.com;))

Recent news on Divi's Laboratories

See all news